|
FY2026
12 months to Jul 3, 2026
|
FY2025
12 months to Jun 27, 2025
|
FY2024
12 months to Jun 28, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jul 1, 2022
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of revenues | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Amortization of intangible assets | |||||
| Restructuring and other charges | |||||
| Acquisition costs and other related expenses | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Change in fair value of derivative instruments, net of tax | |||||
| Foreign currency translation adjustments, net of tax | |||||
| Deferred compensation and pension benefit plan, net of tax | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Total comprehensive loss | |||||
| Basic net (loss) earnings per share (in dollars per share) | |||||
| Diluted net (loss) earnings per share (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...